Article Abstract

Is there a real survival benefit of surveillance for hepatocellular carcinoma in cirrhotic patients?

Authors: Massimo Colombo, Ana Lleo


Surveillance with abdominal ultrasound (US) of patients with chronic liver disease who are at risk of developing a hepatocellular carcinoma (HCC), has progressively emerged as a consolidated practice for achieving early diagnosis and improving treatment of liver cancer, despite the lack of robust evidence-based data.